PACT logo

Steering Committee

Dr Ian Glaspole

Associate Professor Ian Glaspole (Melbourne)

Associate Professor Ian Glaspole is the head of the Alfred Hospital interstitial lung disease clinic and an adjunct clinical associate professor within the Monash University Faculty of Medicine. His research is principally to do with clinical aspects of interstitial lung disease. He is the co-Chair of the Australasian Interstitial Lung Disease Registry and part of a number of NHMRC funded projects, including the Centre for Research Excellence in Pulmonary Fibrosis.

Ian is Chair of Pulmonary Fibrosis Australasian Clinical Trials Network (PACT).

Professor Dan Chambers (Brisbane)

Professor Dan Chambers is a Thoracic and Transplant Physician with long-standing clinical and research interests in lung fibrosis. Dan runs one of the largest pulmonary fibrosis clinical trials centres in Australia. He has been principal investigator for multiple trials from phases 1 to 3 in lung fibrosis, cellular therapy and lung transplantation.

Dan’s research has been supported by over $18 million in competitive grant funding. He is a past Associate Director of the International Lung and Heart-lung Transplant Registry and was the augural PACT Chair 2017 to early 2023.

Professor Tamera Corte (Sydney)

Professor Tamera Corte is a Consultant Respiratory Physician and Director of Interstitial Lung Disease at Royal Prince Alfred Hospital, Sydney. Tamera is a Professor at the University of Sydney and is the Chair of the Australasian Interstitial Lung Disease Registry, and a member of multiple international task forces.

Tamera served as Clinical Fellow in Interstitial Lung Disease at the Royal Brompton Hospital in London and has a PhD in the identification of pulmonary vascular dysfunction in interstitial lung disease. She continues her research at Sydney University, where she is Chief Investigator on a Centre of Excellence NHMRC grant for Pulmonary Fibrosis.

Associate Professor Nicole Goh (Melbourne)

Associate Professor Nicole Goh is a Consultant Respiratory Physician and Director of the Interstitial Lung Disease Unit at Austin Health, Chair of the Medical and Scientific Research Committee at the Institute of Breathing and Sleep. Nicole is Chair of the Rare Lung Disease Network, Lung Foundation Australia and is on the Steering Committee for the Australasian Interstitial Lung Disease Registry.

Dr Goh served as Clinical Fellow in Interstitial Lung Disease at the Royal Brompton Hospital in London and has a PhD in the identification of prognostic markers in scleroderma associated interstitial lung disease. She continues her research at Austin Health and has a particular interest in pulmonary rehabilitation and oxygen therapy in interstitial lung disease.

Professor Anne Holland (Melbourne)

Professor Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Alfred Health in Melbourne, a joint appointment with Monash University. Her research program aims to optimise non-pharmacological management for people with chronic respiratory disease.

Anne led the first randomised controlled trial of pulmonary rehabilitation for people with pulmonary fibrosis, a treatment that is now recommended in clinical guidelines across the world. Her current clinical trials investigate new models of pulmonary rehabilitation to improve access and uptake, and ambulatory oxygen therapy for pulmonary fibrosis. In the CRE for Pulmonary Fibrosis she leads programs to optimise patient education and support, and improve translation of research into best clinical practice.

Dr John Mackintosh (Brisbane)

Dr John Mackintosh is a Respiratory and Lung Transplant Physician at The Prince Charles Hospital, Brisbane. In 2018, John completed a clinical fellowship in interstitial lung disease at the prestigious Royal Brompton Hospital, London.

John has a keen interest in familial pulmonary fibrosis and the genetics of interstitial lung disease. He is a strong advocate for patients with interstitial lung disease and is passionate about the multi-disciplinary approach to these patients. He is the principal investigator at the lead site of an investigator-led clinical trial of danazol in people with pulmonary fibrosis related to telomere shortening (TELO-SCOPE).

Associate Professor Lauren Troy (Sydney)

Associate Professor Lauren Troy is a Consultant Respiratory Physician at Royal Prince Alfred Hospital and Chris O’Brien Lifehouse, and a Clinical Associate Professor at the University of Sydney. She sits on the TSANZ Domiciliary Oxygen task force and international task forces for Idiopathic Pulmonary Fibrosis/ Progressive Pulmonary Fibrosis, and Transbronchial Cryobiopsy for ILD diagnosis. Lauren was the chief investigator of the internationally renowned COLDICE Study, comparing cryobiopsy and surgical lung biopsy for ILD diagnosis.

Lauren completed her PhD in exercise and sleep physiology in ILD and her clinical and research interests include ILD, interventional pulmonology, COVID-19 infection and long-term outcomes, bronchiectasis and education.

Dr Harry Gallagher (Hamilton, New Zealand)

Dr Gallagher is a Respiratory physician and is Head of the Respiratory Department at Waikato Hospital, Te Whatu Ora Health New Zealand. Harry completed a clinic fellowship in lung transplant and pulmonary vascular diseases at The Prince Charles Hospital, Brisbane, in 2013. Harry has an interest in promoting interstitial lung disease research in the New Zealand setting.

Ms Kelcie Herrmann (Brisbane)

Kelcie Herrmann is qualified speech pathologist and General Manager Clinical Programs, Research & Innovation at Lung Foundation Australia. In her role with the Foundation, Kelcie oversees the Hope Research Program and the strategic partnership with the CRE-ILD, including LFA’s investment of $7.3 million over the next 5 years to support priority initiatives within CRE-IPF pillar projects, spanning CREATE, PACT and TEDS.

Ms Jennifer Walsh image

Ms Jennifer Walsh (Sydney)

Jennifer is the PACT Project Manager as well as working as a CRE-PF Project Manager since 2017. Jennifer supports the day-to-day operational activities of PACT, as well as assisting with the collaboration amongst team members and coordination of the various projects.
Jennifer completed a Bachelor of Science at UNSW as well as a Master of Public Health at the University of Sydney. She has extensive research experience with several chronic diseases, including cancer, and has managed various research studies, including multi-centre randomised controlled trials at the University of Sydney, UNSW and Cancer Council Victoria.